DiagnaMed Announces Chief Financial Officer Transition
DiagnaMed Holdings Corp. (OTCQB: DGNMF) announced a leadership transition in its financial department. Jing Peng has stepped down from his position as Chief Financial Officer, effective immediately. The company has appointed Edward Low as Interim CFO, who brings significant experience in corporate finance and accounting for public companies.
Mr. Low will oversee DiagnaMed's financial operations during the transition period while the Board evaluates long-term leadership options. The company continues to focus on its hydrogen development initiatives and operational execution, particularly in Northern Ontario through its QIMC and INRS teams.
DiagnaMed Holdings Corp. (OTCQB: DGNMF) ha annunciato un cambiamento nella leadership del suo dipartimento finanziario. Jing Peng ha lasciato il suo incarico di Chief Financial Officer con effetto immediato. La società ha nominato Edward Low come CFO ad interim, che vanta una significativa esperienza in finanza aziendale e contabilità per società quotate.
Il signor Low supervisionerà le operazioni finanziarie di DiagnaMed durante il periodo di transizione, mentre il Consiglio valuta le opzioni di leadership a lungo termine. L’azienda continua a concentrarsi sulle sue iniziative di sviluppo dell’idrogeno e sull’esecuzione operativa, in particolare nel Nord Ontario attraverso i team QIMC e INRS.
DiagnaMed Holdings Corp. (OTCQB: DGNMF) anunció una transición en el liderazgo de su departamento financiero. Jing Peng renunció a su cargo como Director Financiero, con efecto inmediato. La compañía ha designado a Edward Low como CFO interino, quien aporta una amplia experiencia en finanzas corporativas y contabilidad para empresas públicas.
El Sr. Low supervisará las operaciones financieras de DiagnaMed durante el periodo de transición mientras la Junta evalúa opciones de liderazgo a largo plazo. La empresa sigue enfocada en sus iniciativas de desarrollo de hidrógeno y en la ejecución operativa, especialmente en el norte de Ontario a través de sus equipos QIMC e INRS.
DiagnaMed Holdings Corp. (OTCQB: DGNMF)는 재무 부서의 리더십 변화를 발표했습니다. Jing Peng이 즉시 효력을 발휘하는 최고재무책임자(CFO) 자리에서 물러났습니다. 회사는 공기업의 기업 재무 및 회계 분야에서 풍부한 경험을 가진 Edward Low를 임시 CFO로 임명했습니다.
Low 씨는 이사회가 장기 리더십 옵션을 평가하는 동안 전환 기간 동안 DiagnaMed의 재무 운영을 감독할 예정입니다. 회사는 특히 QIMC 및 INRS 팀을 통해 온타리오 북부에서 수소 개발 이니셔티브와 운영 실행에 계속 집중하고 있습니다.
DiagnaMed Holdings Corp. (OTCQB : DGNMF) a annoncé un changement de direction au sein de son département financier. Jing Peng a démissionné de son poste de Directeur Financier avec effet immédiat. La société a nommé Edward Low Directeur Financier par intérim, qui apporte une vaste expérience en finance d’entreprise et comptabilité pour des sociétés cotées en bourse.
M. Low supervisera les opérations financières de DiagnaMed pendant la période de transition, tandis que le Conseil d’administration évalue les options de leadership à long terme. L’entreprise continue de se concentrer sur ses initiatives de développement de l’hydrogène et sur l’exécution opérationnelle, notamment dans le nord de l’Ontario via ses équipes QIMC et INRS.
DiagnaMed Holdings Corp. (OTCQB: DGNMF) gab einen Führungswechsel in seiner Finanzabteilung bekannt. Jing Peng ist mit sofortiger Wirkung von seiner Position als Chief Financial Officer zurückgetreten. Das Unternehmen hat Edward Low zum Interim CFO ernannt, der über umfangreiche Erfahrung in Unternehmensfinanzen und Rechnungswesen für börsennotierte Unternehmen verfügt.
Herr Low wird während der Übergangsphase die Finanzoperationen von DiagnaMed überwachen, während der Vorstand langfristige Führungsoptionen prüft. Das Unternehmen konzentriert sich weiterhin auf seine Wasserstoffentwicklungsinitiativen und die operative Umsetzung, insbesondere in Nordontario durch seine QIMC- und INRS-Teams.
- Appointment of experienced interim CFO with public company expertise
- Continued focus on hydrogen development initiatives and strategic scaling
- Sudden departure of CFO
- Temporary leadership solution indicating potential uncertainty in financial leadership
Toronto, Ontario--(Newsfile Corp. - July 16, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed" or the "Company") announces that Jing Peng has stepped down as Chief Financial Officer of the Company, effective immediately. The Board of Directors has appointed Mr. Edward Low as Interim Chief Financial Officer.
Mr. Low has extensive experience in corporate finance and accounting for public companies, including financial reporting, regulatory compliance, and strategic planning. He will oversee the Company's financial operations during this transition period while the Board evaluates longer-term leadership needs.
The Board thanks Mr. Peng for his service and contributions to DiagnaMed and wishes him well in his future endeavors.
The Company continues to advance its hydrogen development initiatives and enhance operational execution, strategically scaling its platform to capitalize on growth opportunities within the expanding natural hydrogen sector. This includes the ongoing deployment of the QIMC and INRS teams in Northern Ontario.
About DiagnaMed Holdings Corp.
DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) is a Canadian technology innovator specializing in advanced hydrogen extraction technologies designed to support the rapidly growing natural hydrogen industry. Focused on commercial scalability, DiagnaMed aims to deliver cost-effective, sustainable, and efficient hydrogen solutions critical for global energy security and decarbonization. Visit DiagnaMed.com.
For more information, please contact:
John Karagiannidis, President and CEO
DiagnaMed Holdings Corp.
Tel: 514-726-7058
Email: info@diagnamed.com
Website: www.diagnamed.com
Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release.
Cautionary Statement
Certain statements in this news release are forward-looking statements, including with respect to future plans, and other matters. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Such information can generally be identified by the use of forwarding-looking wording such as "will", "may", "expect", "could", "can", "estimate", "anticipate", "intend", "believe", "projected", "aims", and "continue" or the negative thereof or similar variations. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, including but not limited to, business, economic and capital market conditions, the ability to manage operating expenses, and dependence on key personnel. Such statements and information are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future, anticipated costs, and the ability to achieve goals. Factors that could cause the actual results to differ materially from those in forward-looking statements include, the continued availability of capital and financing, litigation, failure of counterparties to perform their contractual obligations, loss of key employees and consultants, and general economic, market or business conditions. Factors that could cause actual results to differ materially from those anticipated in these forward-looking statements are described under the caption "Risk Factors" in Company's management's discussion and analysis for the Three and Six Months Ended March 31, 2025 ("MD&A"), dated May 28, 2025, which is available on the Company's profile at www.sedarplus.ca. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The reader is cautioned not to place undue reliance on any forward-looking information. The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful, including any of the securities in the United States of America. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "1933 Act") or any state securities laws and may not be offered or sold within the United States or to, or for account or benefit of, U.S. Persons (as defined in Regulation S under the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration requirements is available.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/258985
FAQ
Who is the new interim CFO of DiagnaMed (DGNMF)?
Why did DiagnaMed's CFO Jing Peng step down?
What are DiagnaMed's (DGNMF) current business initiatives?
What is DiagnaMed's plan for permanent CFO leadership?
